Stevanato Group (NYSE:STVN) Shares Gap Up – Should You Buy?

Stevanato Group S.p.A. (NYSE:STVN)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at €19.06 ($20.49), but opened at €19.99 ($21.49). Stevanato Group shares last traded at €19.29 ($20.74), with a volume of 97,308 shares.

Analyst Ratings Changes

A number of analysts recently commented on STVN shares. Wolfe Research began coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price on the stock. Bank of America boosted their target price on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of €28.60 ($30.75).

Stevanato Group Stock Performance

The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The stock’s 50-day moving average price is €21.40 and its 200 day moving average price is €20.51. The company has a market cap of $6.04 billion, a P/E ratio of 42.47, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, meeting the consensus estimate of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. As a group, research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors have recently added to or reduced their stakes in the stock. Zions Bancorporation N.A. acquired a new stake in shares of Stevanato Group during the third quarter worth approximately $1,049,000. Sivik Global Healthcare LLC acquired a new stake in Stevanato Group during the 3rd quarter valued at $2,800,000. King Wealth Management Group boosted its stake in Stevanato Group by 30.2% in the third quarter. King Wealth Management Group now owns 94,800 shares of the company’s stock worth $1,896,000 after purchasing an additional 22,000 shares in the last quarter. Royce & Associates LP grew its holdings in shares of Stevanato Group by 45.8% during the third quarter. Royce & Associates LP now owns 343,159 shares of the company’s stock worth $6,863,000 after purchasing an additional 107,869 shares during the last quarter. Finally, Natixis Advisors LLC increased its stake in shares of Stevanato Group by 20.3% in the third quarter. Natixis Advisors LLC now owns 51,343 shares of the company’s stock valued at $1,027,000 after buying an additional 8,669 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.